BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2903937)

  • 1. Catecholamine metabolism in pheochromocytoma and normal adrenal medullae.
    Nakada T; Furuta H; Katayama T
    J Urol; 1988 Dec; 140(6):1348-51. PubMed ID: 2903937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of mRNA coding for four catecholamine-synthesizing enzymes in human adrenal pheochromocytomas.
    Isobe K; Nakai T; Yukimasa N; Nanmoku T; Takekoshi K; Nomura F
    Eur J Endocrinol; 1998 Apr; 138(4):383-7. PubMed ID: 9578504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydroxyphenylglycol in pheochromocytoma: its diagnostic use for norepinephrine dominant tumor.
    Nakada T; Sasagawa I; Kubota Y; Suzuki H; Ishigooka M; Watanabe M
    J Urol; 1996 Jan; 155(1):14-8. PubMed ID: 7490813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal catecholamine metabolism in pheochromocytoma.
    Rubio MC; Barontini MB
    Medicina (B Aires); 1985; 45(6):631-6. PubMed ID: 2878347
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoamine oxidase A down-regulation contributes to high metanephrine concentration in pheochromocytoma.
    Grouzmann E; Matter M; Bilz S; Herren A; Triponez F; Henzen C; Kim KS; Zulewski H; Buclin T; Brakch N; Abid K
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2773-81. PubMed ID: 22569243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGE2: opposite effect on catecholamine release from phaeochromocytoma and adrenal medulla.
    Gutman Y; Boonyaviroj P
    Prostaglandins; 1976 Oct; 12(4):487-91. PubMed ID: 972999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor.
    Eisenhofer G; Goldstein DS; Kopin IJ; Crout JR
    Endocr Pathol; 2003; 14(3):193-212. PubMed ID: 14586065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyoma-induced neoplasms of the mouse adrenal medulla. Characterization of the tumors and establishment of cell lines.
    Tischler AS; Freund R; Carroll J; Cahill AL; Perlman RL; Alroy J; Riseberg JC
    Lab Invest; 1993 May; 68(5):541-9. PubMed ID: 8098784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral adrenal catecholamine excess. Pheochromocytoma or possible sporadic medullary hyperplasia.
    Bauman A
    Arch Intern Med; 1982 Feb; 142(2):377-8. PubMed ID: 7059264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remarkably suppressed manganese superoxide dismutase activity in malignant pheochromocytoma.
    Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
    J Urol; 1995 Jun; 153(6):1787-90. PubMed ID: 7752317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.
    Eisenhofer G; Walther MM; Huynh TT; Li ST; Bornstein SR; Vortmeyer A; Mannelli M; Goldstein DS; Linehan WM; Lenders JW; Pacak K
    J Clin Endocrinol Metab; 2001 May; 86(5):1999-2008. PubMed ID: 11344198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite effect of PGE2 on cAMP levels in human adrenal medulla and pheochromocytoma.
    Boonyaviroj P; Gutman Y
    Experientia; 1977 Aug; 33(8):1113-4. PubMed ID: 196898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of mRNAs coding for catecholamine synthesizing enzymes in human adrenal pheochromocytoma].
    Isobe K; Yukimasa N; Takekoshi K; Nomura F; Nakai T
    Rinsho Byori; 1995 Jun; 43(6):540-4. PubMed ID: 7602797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphology, Biochemistry, and Pathophysiology of MENX-Related Pheochromocytoma Recapitulate the Clinical Features.
    Wiedemann T; Peitzsch M; Qin N; Neff F; Ehrhart-Bornstein M; Eisenhofer G; Pellegata NS
    Endocrinology; 2016 Aug; 157(8):3157-66. PubMed ID: 27254000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma.
    Lundberg JM; Hamberger B; Schultzberg M; Hökfelt T; Granberg PO; Efendić S; Terenius L; Goldstein M; Luft R
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4079-83. PubMed ID: 386355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine hydroxylase in human adrenal and pheochromocytoma: localization, kinetics, and catecholamine inhibition.
    Waymire JC; Weiner N; Schneider FH; Goldstein M; Freedman LS
    J Clin Invest; 1972 Jul; 51(7):1798-804. PubMed ID: 4402349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
    Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
    PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear DNA ploidy pattern and tissue levels of dihydroxyphenylalanine and catecholamines in pheochromocytoma.
    Sasagawa I; Nakada T; Kubota Y; Ishigooka M; Sawamura T; Suzuki Y
    Urol Int; 1995; 54(4):181-3. PubMed ID: 7610501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma.
    Peaston RT; Lennard TW; Lai LC
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1378-84. PubMed ID: 8636337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of urotensin II mRNA in normal adrenal medulla and pheochromocytoma tissues].
    Liu GQ; Zeng ZP; Li HZ; Fan XR; Liu DM; Tong AL; Zheng X
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1225-8. PubMed ID: 12930635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.